WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061407) SCHISTOSOMA VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061407    International Application No.:    PCT/US2008/012486
Publication Date: 14.05.2009 International Filing Date: 05.11.2008
IPC:
A61K 39/00 (2006.01), A61P 33/12 (2006.01)
Applicants: RHODE ISLAND HOSPITAL [US/US]; 593 Eddy Street, Providence, RI 02903 (US) (For All Designated States Except US).
KURTIS, Jonathan [US/US]; (US) (For US Only).
JIZ, Mario [PH/US]; (US) (For US Only).
WU, Haiwei [CN/US]; (US) (For US Only).
POND-TOR, Sunthorn [US/US]; (US) (For US Only)
Inventors: KURTIS, Jonathan; (US).
JIZ, Mario; (US).
WU, Haiwei; (US).
POND-TOR, Sunthorn; (US)
Agent: BEATTIE, Ingrid, A.; Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C, One Financial Center, Boston, MA 02111 (US)
Priority Data:
61/002,070 05.11.2007 US
Title (EN) SCHISTOSOMA VACCINE
(FR) VACCIN CONTRE LES SCHISTOSOMES
Abstract: front page image
(EN)The method for large scale production of a full length Schistosomal paramyosin coiled coil dimer composition is carried out by providing a composition comprising recombinant paramyosin, contacting the composition with a strand separation agent to remove paramyosin fragments and other contaminants. The purified paramyosin is used in vaccines for humans and bovine animals to induce immunity against schistosomal infection.
(FR)L'invention porte sur un procédé pour une production à grande échelle d'une composition de dimère en super hélice de la paramyosine schistosomale de longueur entière. Ce procédé est réalisé par les opérations consistant à se procurer une composition comprenant de la paramyosine recombinante, mettre en contact la composition avec un agent de séparation de brins pour retirer les fragments de paramyosine et autres contaminants. La paramyosine purifiée est utilisée dans des vaccins pour les êtres humains et les animaux bovins afin d'induire une immunité contre une infection schistosomale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)